Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Coherus BioSciences, Inc. (CHRS)

« Back to company index

CHRS Chatter Timeline

Stock Ticker for CHRS

Most Active Tweeters for CHRS

UserTweets
@Tickeron 7
@stockmktgenius 5
@ZolmaxNews 2
@ThisLincolnian 1
@Gambiste1 1

Recent Tweets for CHRS

Tickeron @Tickeron
$CHRS's Aroon indicator drops into Downtrend on September 3, 2019. View odds for this and other indicators:… https://t.co/dYln8umDsR
September 13th 2019, 9:09pm
stockmktgenius @stockmktgenius
$CHRS Coherus BioSciences, Inc. #LeaderPullBack Close: 20.20 Liq: $10M https://t.co/PM5S1zW6Uw
September 13th 2019, 6:09pm
dakotafinancial @dakotafinancial
Coherus Biosciences Inc $CHRS Given Consensus Rating of “Buy” by Brokerages https://t.co/T7Z4BAcqma
September 13th 2019, 11:09am
AmericanBanking @AmericanBanking
Coherus Biosciences Inc $CHRS Given Consensus Rating of “Buy” by Brokerages https://t.co/eAjkwVtFOL #stocks
September 13th 2019, 10:09am
thebiotechforum @thebiotechforum
The Play On Coherus BioSciences $CHRS https://t.co/M5QllqAFvS
September 13th 2019, 9:09am
Gambiste1 @Gambiste1
RT @bret_jensen: $CHRS - The Play On Coherus BioSciences https://t.co/3JLMieoyuy
September 13th 2019, 8:09am
bret_jensen @bret_jensen
$CHRS - The Play On Coherus BioSciences https://t.co/3JLMieoyuy
September 13th 2019, 7:09am
SeekingAlpha @SeekingAlpha
$CHRS - The Play On Coherus Biosciences https://t.co/QjRcKFmyBf
September 13th 2019, 1:09am
stockmktgenius @stockmktgenius
$CHRS Coherus BioSciences, Inc. #LeaderPullBack Close: 19.94 Liq: $10M https://t.co/PM5S1zW6Uw
September 12th 2019, 6:09pm
nfp_ea @nfp_ea
RT @Tickeron: $CHRS's Aroon indicator drops into Downtrend on September 3, 2019. View odds for this and other indicators: https://t.co/87AP…
September 12th 2019, 6:09pm
Tickeron @Tickeron
$CHRS's Aroon indicator drops into Downtrend on September 3, 2019. View odds for this and other indicators:… https://t.co/gw30Cxedfj
September 12th 2019, 6:09pm
PunditPatent @PunditPatent
$CHRS Yesterday, the USPTO instituted challenges brought by Kashiv on key Amgen Neulasta patents. This will help cl… https://t.co/q8UC1DW09Y
September 12th 2019, 9:09am
stockmktgenius @stockmktgenius
$CHRS Coherus BioSciences, Inc. #LeaderPullBack Close: 20.30 Liq: $13M https://t.co/PM5S1zW6Uw
September 12th 2019, 12:09am
Tickeron @Tickeron
$CHRS's Aroon indicator drops into Downtrend on September 3, 2019. View odds for this and other indicators:… https://t.co/OQFw87mSjJ
September 11th 2019, 7:09pm
Tickeron @Tickeron
$CHRS's Aroon indicator drops into Downtrend on September 3, 2019. View odds for this and other indicators:… https://t.co/OhOLWHbwMm
September 10th 2019, 6:09pm
stockmktgenius @stockmktgenius
$CHRS Coherus BioSciences, Inc. #LeaderPullBack Close: 19.94 Liq: $19M https://t.co/PM5S1zW6Uw
September 10th 2019, 6:09pm
WatchlistN @WatchlistN
Coherus Biosciences $CHRS Downgraded to Hold at BidaskClub https://t.co/ZoFfAJfIaQ
September 10th 2019, 5:09am
dailypoliticaln @dailypoliticaln
BidaskClub Downgrades Coherus Biosciences $CHRS to Hold https://t.co/pegrllc2ki
September 10th 2019, 5:09am
ZolmaxNews @ZolmaxNews
Coherus Biosciences $CHRS Downgraded to Hold at BidaskClub https://t.co/O4W0MQheFX
September 10th 2019, 5:09am
stockmktgenius @stockmktgenius
$CHRS Coherus BioSciences, Inc. #LeaderPullBack Close: 19.70 Liq: $16M https://t.co/PM5S1zW6Uw
September 9th 2019, 9:09pm
Tickeron @Tickeron
$CHRS's Aroon indicator drops into Downtrend on September 3, 2019. View odds for this and other indicators:… https://t.co/kMC6gx6Bv4
September 9th 2019, 6:09pm
ChartMill @ChartMill
$CHRS's low PEG Ratio, which compensates the PE for growth, indicates a rather cheap valuation.… https://t.co/mhhEF0pi7X
September 9th 2019, 3:09pm
TickerReport @TickerReport
Coherus Biosciences $CHRS Downgraded to Hold at BidaskClub https://t.co/SACSV5KdLU
September 9th 2019, 7:09am
Tickeron @Tickeron
$CHRS's Aroon indicator drops into Downtrend on September 3, 2019. View odds for this and other indicators:… https://t.co/FH09KKct5v
September 8th 2019, 4:09pm
bbnsnews @bbnsnews
Coherus Biosciences $CHRS Lowered to “Hold” at ValuEngine https://t.co/6ueMlP4ojb
September 8th 2019, 2:09am
Tickeron @Tickeron
$CHRS's Aroon indicator drops into Downtrend on September 3, 2019. View odds for this and other indicators:… https://t.co/nv8EsphJm4
September 7th 2019, 6:09pm
OlympiaReport @OlympiaReport
Coherus Biosciences $CHRS Lowered to “Hold” at BidaskClub https://t.co/UZr5LfPTpc
September 7th 2019, 11:09am
ThisLincolnian @ThisLincolnian
Coherus Biosciences $CHRS Lowered to “Hold” at BidaskClub https://t.co/vnPDpqclaI
September 7th 2019, 10:09am
WeekHerald @WeekHerald
Coherus Biosciences $CHRS Stock Rating Lowered by BidaskClub https://t.co/nourJJV5z7
September 7th 2019, 10:09am
ZolmaxNews @ZolmaxNews
Coherus Biosciences $CHRS Downgraded by ValuEngine to “Hold” https://t.co/16mpBXBoSX
September 7th 2019, 9:09am
dispatchtribune @dispatchtribune
Coherus Biosciences Inc $CHRS Expected to Post Earnings of $0.36 Per Share https://t.co/YbpNSs8qLI
August 11th 2019, 7:08pm
OlympiaReport @OlympiaReport
$0.36 EPS Expected for Coherus Biosciences Inc $CHRS This Quarter https://t.co/lNUiAa4YyY
August 11th 2019, 7:08pm
ThisLincolnian @ThisLincolnian
$93.58 Million in Sales Expected for Coherus Biosciences Inc $CHRS This Quarter https://t.co/JlCle26bjX
August 11th 2019, 7:08pm
WeekHerald @WeekHerald
Coherus Biosciences Inc $CHRS Expected to Post Earnings of $0.36 Per Share https://t.co/VgE35hO3RZ
August 11th 2019, 7:08pm
ConsumerFeed @ConsumerFeed
Analysts Expect Coherus Biosciences Inc $CHRS to Post $0.36 EPS https://t.co/xm1KVMIMdy
August 11th 2019, 7:08pm
WatchlistN @WatchlistN
$93.58 Million in Sales Expected for Coherus Biosciences Inc $CHRS This Quarter https://t.co/epc5kDLjfE
August 11th 2019, 7:08pm
dailypoliticaln @dailypoliticaln
Coherus Biosciences Inc $CHRS Expected to Post Quarterly Sales of $93.58 Million https://t.co/GCGpu1XZgy
August 11th 2019, 7:08pm
Tickeron @Tickeron
$CHRS's 10-day Moving Average broke below its 50-day Moving Average on July 19, 2019. View odds for this and other… https://t.co/19vy2jeKo4
August 11th 2019, 4:08pm
MarketChmln @MarketChmln
$CHRS option volume was 8X normal on Friday with 2,488 contracts. Call volume was 95% and put volume was 5%. https://t.co/FUa2SmtDGB
August 10th 2019, 6:08pm
Tickeron @Tickeron
$CHRS's 10-day Moving Average crossed below its 50-day Moving Average on July 19, 2019. View odds for this and othe… https://t.co/QbuWjZr4TH
August 10th 2019, 6:08pm
TickerReport @TickerReport
Investors Buy Large Volume of Coherus Biosciences Call Options $CHRS https://t.co/ow3ptCHTjs
August 10th 2019, 1:08am
TranscriptDaily @TranscriptDaily
Investors Buy Large Volume of Coherus Biosciences Call Options $CHRS https://t.co/0Y1V6CHN5P
August 10th 2019, 1:08am
Tickeron @Tickeron
$CHRS in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/tlmuF5CHhi
August 9th 2019, 6:08pm
MarketCurrents @MarketCurrents
$CHRS - Coherus down 3% on Enbrel patent ruling https://t.co/z8kBdMq5jS
August 9th 2019, 4:08pm
bbnsnews @bbnsnews
Coherus Biosciences Inc $CHRS Expected to Post Earnings of $0.36 Per Share https://t.co/P5EsKtp5if
August 9th 2019, 3:08pm
TickerReport @TickerReport
Zacks: Analysts Expect Coherus Biosciences Inc $CHRS Will Post Earnings of $0.36 Per Share https://t.co/AQPXQGwV2Y
August 9th 2019, 2:08pm
AmericanBanking @AmericanBanking
Investors Buy Large Volume of Call Options on Coherus Biosciences $CHRS https://t.co/Olkx9YhA1Q #stocks
August 9th 2019, 9:08am
stockmktgenius @stockmktgenius
$CHRS Coherus BioSciences, Inc. #LeaderPullBack Close: 19.71 Liq: $15M https://t.co/PM5S1zW6Uw
August 8th 2019, 6:08pm
Tickeron @Tickeron
$CHRS in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/O8FxmQ6llc
August 8th 2019, 5:08pm
AmericanBanking @AmericanBanking
Coherus Biosciences Inc $CHRS Expected to Post Quarterly Sales of $93.58 Million https://t.co/NJOYF8FoSz #stocks
August 8th 2019, 4:08am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.